ackground. We explored decisional conflict as measured with the 16-item Decisional Conflict Scale (DCS) and how it varies across clinical situations, decision types, and exposure to decision support interventions (DESIs). Methods. An exhaustive scoping review was conducted using backward citation searches and keyword searches. Eligible studies were published between 1995 and March 2015, used an original experimental/observational research design, concerned a health-related decision, and provided DCS data. Dyads independently screened titles/ abstracts and full texts, and extracted data. We performed narrative syntheses and calculated average or median DCS scores. Results. We included 246 articles reporting on 253 studies. DCS scores ranged from 2.4 to 89.6 out of 100. Highest baseline DCS scores were for care planning (30.5 6 12.8, median = 30.9) and treatment decisions (30.5 6 14.6, median = 28.0), in contexts of primary care (33.8 6 19.8), obstetrics/gynecology (28.8 6 10.4), and geriatrics (32.6 6 10.7). Baseline scores were high among decision makers who were ill (29.5 6 13.8, median = 27.2) or making decisions for themselves (29.7 6 14.8, median = 26.9). Total DCS scores \25 out of 100 were associated with implementing decisions. Without DESIs, DCS scores tended to increase shortly after decision making (.37.4). After DESI use, DCS scores decreased short-term but increased or remained the same long-term (.6 months). Conclusions. DCS scores were highest at baseline and decreased after decision making. DESIs decreased decisional conflict immediately after decision making. The largest improvements after DESIs were in decision makers who were ill, male, or made decisions for themselves. Meta-analyses focusing on decision types, contexts, and interventions could inform hypotheses about the expected effects of DESIs, the best timing for measurement, and interpretation of DCS scores.
The Decisional Conflict Scale (DCS) was developed in 1995 to measure decisional conflict and related factors, enable the tailoring of decision support interventions (DESIs) to patients' decisional needs, and evaluate the effectiveness of DESIs. [1] [2] [3] [4] [5] The DCS measures 5 dimensions of decision making (feeling uncertain about the best course of action, feeling uninformed, feeling unclear about values, and feeling unsupported; ineffective decision making). Currently the original DCS and 2 other versions entitled the low-literacy DCS 6 and the SURE test are used with patients. [7] [8] [9] [10] The DCS has been used in many contexts, decision types, and stages of decision making. Several studies have demonstrated the positive effects of DESIs on total DCS and subscale scores, decision quality, and decision delay. 6 However, DCS scores have been reported to vary significantly across contexts and decisions. 8 Hence, to determine acceptable changes in the DCS after interventions, it is important to be aware of such differences and to take them into account in power analysis to determine the sample size for studies.
We conducted a scoping review and found that over the initial 20 years of its existence, the DCS was used in 394 research articles (404 studies) originating in 23 countries. 10 DCS versions, applications, and use have increased steadily since development of the traditional DCS in 1995. It has been used for multiple decision types, clinical contexts, and populations, demonstrating its value as a decision-making evaluation measure. The traditional 16-item version of the DCS was used in at least 246 of these 394 research articles (1995 to 2015). 10 The traditional DCS is a 16-item scale, measuring 5 dimensions of decision making. Each item is measured on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree), leading to a total score of between 16 and 54, which is typically transformed to a standardized score of 0 to 100. Scores of less than 25 are associated with being able to implement a decision, whereas those greater than 37.5 are associated with decision delay. 6 In addition, although these cutoffs are increasingly used to imply clinical significance, this has not been explored beyond the original studies. The scale has excellent psychometric properties with test-retest correlations exceeding a = 0.78, good construct validity (discriminates between groups, effect size [ES]: 0.4-0.8), and responsiveness to change (ES: 0.4-1.2). 6 The lowliteracy version consists of 10 items measured on a 3-point scale (yes, no, unsure), and the SURE test consists of 4 items, measured on a 2-point scale (yes, no) to screen for clinically elevated decisional conflict.
Since there is no known reference level of decisional conflict available for different subgroups, it is difficult to compare results with other populations, generalize findings, or determine what is an acceptable increase or decrease in DCS scores. In this study, we explored the overall levels of DCS scores as measured with the traditional 16-item scale and how these levels vary across different clinical and decision contexts, participant characteristics, and exposure to DESIs.
Methods

Design
We conducted a subgroup analysis of a larger scoping review guided by Arksey and O'Malley's 6-step methodological framework 11 and Levac's recommendations for rigor in scoping reviews. 12 We registered our review in Prospero (registration number CRD42014013556). We briefly describe our methods in this article; however, a more detailed description of the full scoping review methods is published in a parallel descriptive article. 10 
Research Questions
We addressed the following research questions: 
Selection of Studies and Data Extraction
We performed a sensitivity analysis of studies that reported using DCS versions other than the 16-item traditional scale to see if the results were consistent across versions. We found that DCS scores measured with the traditional DCS were higher than when measured with the other versions (low literacy, modified traditional scales, subscales only; Table 1 ). Hence, to present the most meaningful results, in this article we focus on the most common version of the DCS (the traditional 16-item DCS). Of the 394 included studies in our scoping review, 10 we selected studies that used the traditional DCS and excluded studies reporting on other DCS versions.
Synthesis of Results
Data handling. We used elements of the Ottawa Decision Support Framework (ODSF) as our conceptual underpinnings for data synthesis. 11, 13 In accordance with the ODSF, we structured our data as baseline decisional needs (e.g., DCS scores per participant and contextual characteristics) and impact of decision making and exposure to DESIs (e.g., DCS scores after decision making or interventions).
If not done, we recoded all continuously measured DCS (total and subscale) scores from 0 to 100. Then, we categorized findings into 1 of 3 groups: 1) control (participants of intervention studies who did not receive an intervention), 2) intervention (participants who received a DESI), and 3) general population (participants of observational studies who did not receive an intervention). In our analyses, we did not distinguish between different types of DESIs. Timing of measurement was categorized as baseline (before decision making), during decision making, immediately after decision making (less than 1 month), shortly after decision making (between 1 and 6 months), and in the long term after decision making (.6 months). Although we present the baseline DCS for a subsample of detailed decisions (i.e., the highest baseline scores), because of the large variety of contexts and decisions, 10 we decided to subcategorize decision types into 6 decisions (care planning, communication, treatment, obstetrics, testing [screening and diagnostic testing], and other), and we report data on the 7 most prevalent contexts (defined as being reported in .5% of the studies) only for the remaining analyses (oncology, primary care, obstetrics/gynecology/urology, genetics, cardiology). Omitted contexts were ear-nose-throat, endocrinology, gastroenterology, infectiology, intensive care, lung, neurology, orthopedics, pediatrics, palliative care, physiotherapy, rheumatology, urology, rehabilitation, various (multiple contexts), and other.
Pooling and statistical analysis. Data were pooled according to group and timing as well as decision type or context. For specific decisions with the highest baseline needs, we assessed the effect of DESIs on mean DCS immediately after (.1 month), shortly after (between 1 and 6 months), and in the long term after decision making (.6 months). Only scales ranging from 0 to 100 were used (1-5 scales were recalculated to 0-100). N/A = not applicable.
b n = number of articles. This does not correspond to the number of studies or articles, as there could be multiple groups and observations per study. Mean scores were not weighted.
We performed narrative data synthesis including descriptive numerical summaries of the included studies.
For each group or characteristic, we calculated mean DCS scores and standard deviations (SDs), and, if data were skewed (-2 \ kurtosis . 2), we calculated median scores. In addition, x 2 tests were used to calculate differences between categorical variables, and analyses of variance were used to calculate differences between continuous variables, with least significant difference post hoc tests. Results were considered statistically significant if P \ 0.05.
Results
Study Selection
We included 246 articles (62% of the 394 included articles in the full scoping review 10 ; Supplementary Appendix 1), reporting on 253 studies that used the traditional DCS (6 articles contained multiple substudies that are reported as separate results in this article). The other 148 articles (38%) were excluded because they reported on other versions of the DCS such as a modified traditional DCS (n = 24), the low-literacy DCS, the SURE, the Provider Decision Process Assessment Instrument, the pictorial DCS, and subscales only.
Study Characteristics
Publications originated in 18 countries or combinations of countries on 4 continents ( Table 2 ). Most studies used comparative designs (n = 158, 62%) and analyzed continuous scores on a scale from 1 to 5 or standardized the scores from 0 to 100. Although many studies reported existing cutoffs for clinically significant decisional conflict in their methods (\25 versus .37.5 on a scale from 0-100 or \2 versus .2.5 on a scale from 0-5) and compared their results to these cutoffs, only 1 study dichotomized their data (yes or no, exact cutoff point not reported). 14 
Baseline DCS per Study Design
Total DCS. Baseline total DCS ranged from 1.5 to 88.0 (mean = 28.8 6 14.7, median = 26.5). Mean baseline DCS (preintervention) was slightly lower in the intervention groups (mean = 27.5 6 13.7, median = 25.0) than in the control groups (mean = 31. The highest baseline scores were in the intervention and control groups (compared with the observational groups) for the ineffective decision making scale (control: mean = 31.1 6 17.3, median = 27.5; intervention: mean = 27.7 6 14.8, median = 25.1; population: mean = 20.1 6 12.2, median = 19.4) and the feeling uncertain subscales (control: mean = 32.8 6 14.9, median = 32.3; intervention: mean = 33.6 6 13.6, median = 35; population: mean = 28.8 6 13.8, median = 25.6; Figure 1 ).
Continents. There was a statistically significant difference in mean DCS scores between continents, with European (mean = 32.4 6 16.8, median = 27.6; 59 studies) and North American (mean = 28.2 6 13.6, median = 26.2; 161 studies) studies reporting higher baseline DCS scores than Australian studies (mean = 26.1 6 8.6, median = 25.1; 18 studies) and Asian studies (mean = 22.9 6 8.1, median = 10.3; 12 studies), F(620, 4) = 5.43, P . 0.001.
Clinical context. The most commonly reported clinical decision contexts were oncology (n = 66, 26%), primary care (n = 58, 23%), obstetrics and gynecology (n = 37, 15%), genetics (n = 20, 8%), and cardiology (n = 14, 6%).
Overall, baseline DCS scores were highest in primary care (mean = 33.8 6 19.8) and obstetrics and gynecology (28.8 6 10.4), although scores in each context sometimes varied between different groups (control v. intervention v. population; Figure 2 ).
General and Specific Decision Types (Decision Topics)
The most commonly reported decision types were treatment (n = 147, 59%), testing (n = 53, 21%; Figure 3) , and care planning (n = 18, 7%). Overall, the highest baseline DCS score was in care planning (mean = 30.5 6 12.77, median = 30.9) and treatment decisions (30.5 6 14.6, median = 28.0).
More specifically, baseline clinically significant DCS scores were found for many specific decisions (Table 3) , with the highest baseline scores in the context of mental disorder treatment (mean = 52.7 6 6.9, median = 52.7), palliative care (end-of-life decisions and advanced care Care planning: amyotrophic lateral sclerosis care (n = 1), benign prostatic hyperplasia treatment (n = 1), cancer management (n = 1), end-of-life/advanced care planning (n = 7), feeding options (n = 5), intensive care decisions (n = 1), life-threatening complications (n = 1), treatment of children with life-threatening illness (n = 1)
(7)
Communication: genetic testing (n = 1), mental health disorder (n = 1), work rehabilitation (n = 1), terminal prognosis communication (n = 1)
(2)
Treatment (medication/surgery): anesthesia for children (n = 1), antibiotic treatment (n = 2), cancer prevention (n = 6), cancer treatment (n = 53), cardiovascular treatment (n = 13), cochlear implant (n = 1), chronic obstructive pulmonary disease treatment (n = 1), dental treatment (n = 1), diabetes treatment (n = 10), fertility treatment (n = 2), fertility preservation (n = 4), fibromyalgia treatment (n = 2), fracture prevention (n = 1), HIV treatment (n = 1), hepatitis C virus treatment (n = 1), infant care (n = 1), inflammatory bowel syndrome decisions (n = 1), influenza treatment (n = 1), knee surgery (n = 2), menopausal treatment (n = 14), menorrhagia treatment (n = 1), mental health treatment (n = 9), multiple sclerosis treatment (n = 3), musculoskeletal treatment (n = 5), osteoporosis treatment (n = 1), palliative care for children (n = 2), psoriasis treatment (n = 1), bariatric/obesity surgery (n = 1), lung transplantation (n = 1), orthopedic treatment (n = 2), plastic surgery (n = 1), dialysis (n = 1), vasectomy (n = 1)
(58)
Obstetrics: childbirth stress (n = 1), delivery mode childbirth (n = 3), pain relief in labor (n = 2), pregnancy termination (n = 2)
(3)
Screening: cancer diagnostic testing (n = 2), cancer screening (n = 23), diabetes testing (n = 1), genetic testing (n = 11), genome sequencing (n = 2), prenatal testing (n = 14)
53 (21) Other: multiple decisions (n = 8), enlarging families (n = 1), respite care (n = 1), trial participation (n = 5), vaccination (n = 7)
22 (9) planning, mean = 49.1 6 11.4, median = 47.5), and menopausal treatment (mean = 45.7 6 13.9, median = 45).
Populations Targeted
Decision maker. Based on available data, we compared people who decided for themselves versus those who decided for others. Surrogate decisions were either for a child (n = 17) or for a loved one with dementia (n = 6).
Baseline mean scores for people who decided for themselves were 29.7 (SD = 14.8, median = 26.9; n = 217 studies), compared with 24.0 (SD = 13.6, median = 22.5; n = 25 studies) for those who decided for someone else (Figure 4 ). At baseline, the DCS score was significantly higher for decisions made for one's self, F(2, 618) = 4.31, P \ 0.05. No differences were found in baseline scores between decisions for adults (mean = 29.1, SD = 14.9, median = 26.5) versus for children (mean = 25.1, SD = 11.2, median=26). Sex. Baseline mean scores in studies with females only were 28.2 (SD = 12.4, median = 25.1; n = 97 studies), compared with 27.9 (SD = 10.1, median = 27.9; n = 33 studies) in studies with only males (Figure 4 ).
Studies including females only reported more decisions in obstetrics and gynecology contexts, whereas studies including males only reported more on care-planning decisions. n is the number of observations that are taken into account to calculate the means. Mean scores were not weighted.
Healthy versus sick. The mean baseline DCS score for healthy people was 27.3 (SD = 10.7, median = 25.5; n = 80 studies), compared with 29.5 (SD = 13.8, median = 27.2; n = 147 studies), F(1, 535) = 4.31, P \ 0.05, for ill people (Figure 4 ). Healthy populations faced more decisions in obstetrics and gynecology and screening/prevention, whereas sick populations faced more treatment decisions.
Post-decision support
A variety of DESIs were used in the included studies, including, but not limited to, online and paper-based decision aids, brochures and pamphlets, online information, educational videos, interactive trainings, and different ways of framing the information.
Effect of Interventions versus No Interventions
Total DCS. Overall mean DCS scores were 23.6 (SD = 9.9, median = 22.9) immediately after decision making, 26.1 (SD = 13.3, median = 24.5) shortly after, and 26.3 (SD = 17.6, median = 21.5) over the long term. Across groups, there were no differences between immediately after decision making and in the long term, but shortly after decision making control groups reported significantly higher decisional conflict (mean = 29.8, SD = 15.8, median = 27.5) than the intervention groups (mean = 24.4, SD = 12.0, median = 22.5), F(2, 768) = 12.7, P \ 0.001. DCS scales. The overall mean DCS scores for the subscales shortly after decision making were feeling uncertain (mean = 30.2 6 13.4, median = 29.8), feeling uninformed (mean = 24.7 6 13.4, median = 23.3), feeling unclear about values (mean = 24.7 6 9.4, median = 24.1), feeling unsupported (mean = 25.3 6 12.8, median = 24.4), and ineffective decision making (mean = 24.9 6 14.9, median = 22.5).
Intervention effects were most apparent in the uninformed and ineffective decision-making subscales. Mean total DCS for the uninformed and ineffective decisionmaking subscales were higher in control groups immediately after decision making (uninformed: mean = 29.0 6 16.7, median = 27.5 and ineffective decision making: mean = 24.5 6 6.8, median = 22.9) than in the intervention groups (informed: mean = 22.1 6 11.8, median = 22.5 and ineffective decision making: mean = 19.4 6 6.7, median = 20), even though baseline scores were lower in the control groups. However, scores in both groups remained below the cutoff for clinically significant DCS scores. Other subscales showed similar results in both groups (Figure 1 ).
Clinical contexts. Immediately after decision making, total DCS scores decreased in all contexts compared with baseline ( Figure 2) . For most contexts, intervention group DCS scores at short-term follow-up decreased compared with baseline but decreased no further in the long term (but remained below baseline levels of DCS). In the absence of interventions, DCS scores in all contexts increased in the short term (in observational studies sometimes above baseline levels).
Decision types. Overall, DCS scores decreased immediately and shortly after decision making, but for careplanning decisions, they increased in the long term.
In the intervention and control groups, immediately or shortly after decision making, DCS scores decreased for most decision types compared with baseline. For most decisions, intervention group DCS scores decreased even in the long term. For screening decisions, DCS scores increased between immediately (\1 month) and shortly after (1-6 months) decision making ( Figure 3) .
After using DESIs (interventions groups), most decisions showed clear decreases in decisional conflict between baseline and the long term after decision making. With regard to specific decisions (Table 3) , all mean DCS scores decreased shortly after decision making.
Decision-maker characteristics
Self versus other. Overall, immediately after decision making, DCS scores were significantly higher for surrogate decision makers than in decisions made for one's self (mean = 31.7 6 10.5 v. mean = 22.3 6 9.1), F(2, 291) = 16.5, P \ 0.001, whereas shortly after decision making (mean = 26.9 6 13.5 v. mean = 20.2 6 10.8) and in the long term (mean = 13.67 6 11.9 v. mean = 28.1 6 1.7), DCS scores were lower for surrogate decision makers, F(2, 767) = 12.9, P \ 0.001.
In control and intervention groups, for both types of decision makers, DCS scores decreased over time compared with baseline, irrespective of whether DESIs were used.
However, in the control groups, DCS scores only for surrogate decisions decreased below clinically significant decisional conflict when no interventions were used (Figure 4) .
In observational studies, DCS scores increased shortly after decision making in both groups (Figure 4) . Sex. Baseline DCS scores were similar between sexes, and few differences were found for measurement timing between the groups (Figure 4) . However, among females, DCS scores generally decreased continuously over time, irrespective of whether DESIs were used or not.
Among males, DCS scores decreased immediately after decision making but increased again in the short and long term in the control and intervention groups. When interventions were used, DCS scores increased only in the long term, and levels remained below baseline. When no interventions were used (control group, population), DCS scores increased (to clinically significant levels), even when compared with their baseline DCS level.
Healthy versus sick. In general, DCS scores were significantly lower in ill versus healthy decision makers (Figure 4) .
When interventions were used, healthy people's DCS scores decreased shortly after decision making but increased again in the long run. Among sick people, DCS scores decreased even in the long term.
In observational studies without interventions (population), healthy decision makers reported lower DCS scores across all measurement moments, especially in the long term.
Discussion
This study provides an overview of 253 studies (from 246 articles) that used the traditional DCS. We compared DCS scores across different clinical and decision contexts, differing participant characteristics, and exposure to DESIs. Overall, we found that DCS scores were high at baseline (often above the original threshold for clinically significant decisional conflict) and decreased after decision making. DCS scores showed different patterns over time in different clinical contexts and populations (sex, health status) and depending on whether the decision was for one's self or someone else (e.g., child, person with dementia). The highest scores were found for decisions for oneself, about treatment when ill, in primary care or end-of-life care contexts, and for male decision makers. Intervention effects (difference between control and intervention groups) were most noticeable shortly after decision making but were also present immediately after decision making and in the long term. These results led us to make 3 observations. First, our findings indicate that DCS scores for individuals exposed to DESIs generally decreased shortly after decision making, consistent with the literature, 15 and justifying the general aim of DESIs to reduce decisional conflict in terms of personal perceptions of feeling uncertain about the best course of action, feeling uninformed, unclear values, feeling unsupported, and ineffective decision making. Moreover, the range of scores of the different time points provided some evidence for currently used cutoff points (25 \ DCS . 37). However, DCS scores were not reduced in all individual studies, nor was the effect always present shortly after decision making. 15 Variations in effect may be attributable to the type of DESIs, the health or health delivery context, the baseline decisional needs, and the complexity of the decision being made. Some studies suggest decisional conflict may increase when new options are presented and/or values elicited, before assimilation with prior knowledge has been achieved. 16, 17 Moreover, fluctuations in DCS scores over time might reflect a typical decision-making process. For example, if a person is unaware that they have options, or that the decision depends on their personal values, an intervention that provides information about options or a values clarification exercise might increase total DCS scores or subscores until a person has fully absorbed or processed the information to make a decision. 16 Moreover, the uncertainty subscore may decrease only after a patient has discussed the decision with the health professional who is sharing in the decision. 17 When measuring the effectiveness of DESIs, the hypothesized effect should be adapted to the contents of the DESIs, as well as the decision context and care trajectory. 18 Second, in this review, DCS scores tended to be high at baseline (often above thresholds for clinically significant decisional conflict, albeit with large standard deviations). Whether or not interventions were given, DCS scores decreased immediately after decision making. However, DESIs seemed to prolong this effect into the long term (.6 months after decision making). In the absence of interventions, DCS scores increased in the short term (1-6 months). These results suggest, in addition to positive effects of DESIs on short-term DCS scores, that decisional conflict is highly dependent on decision-making stage (openness to options, information) and the timing of measurement. 19, 20 It should be taken into account that decision making and related decisional conflict is a process, and sometimes follow-up decisions have to be made (e.g., medication renewal, dealing with increasing joint pain) that might increase decisional conflict in the long term, as many health care-related decisions should be reconsidered after some time. Moreover, decisions are not always made in one discrete consultation but over time in a process of care, with different health professionals. In addition, the act of measuring decisional conflict might increase decisional conflict if, for example, it is measured before the person is aware of the options or has spoken to a health care provider or when decision making is ''closed'' and is then reinitiated by having to reflect on it again. Therefore, it is still important to determine the right measurement timing and outcomes measures that are completed at the same time as DCS (such as decisional stage, decision type, contents of the DESI).
Third, in keeping with the literature, our analysis of mean DCS scores suggests that DCS scores were higher among people making decisions for themselves 21 and individuals who were ill as opposed to healthy. Explanations can be sought in their feelings of responsibility over decision making or the perceived threat of illness that might make decisions harder and may evoke higher DCS scores. The high baseline scores in these populations, as well as in specific decision-making contexts such as end of life and primary care, indicate that people facing decisions in these contexts might benefit the most from DESIs. In addition, in line with the literature in which sex effects were found in different studies but with no clear direction of the effect, we found no obvious baseline differences in DCS scores between male and female decision makers. 21 However, the increased DCS scores in males who did not receive DESIs (compared with a steady decrease in DCS scores in females) may indicate they are a good target for DESIs. Alternatively, decision context and type faced by males and females might differ, as could sex-specific characteristics (e.g., psychological responses and coping).
Finally, in the current era of increased patient-and family-centered care, patients are increasingly involved in decisions regarding their health, which may increase uncertainty and decisional conflict. Measuring DC is useful for evaluating DESI impacts and for determining how to tailor DESIs for particular patients' needs.
14 The traditional DCS is the most common measure for doing so, and it has been used worldwide for multiple decision types, clinical contexts, and populations, demonstrating its value as a decision-making evaluation measure. 10 Although this article provides an overview of how DC scores may evolve over time for different decision types and contexts, which is useful as a reference for future research, it is important to perform more specific metaanalyses focusing on one specific context or decision at a time and distinguishing between different DESIs to provide more detailed information and to determine what magnitude of difference might be clinically meaningful.
Strengths and Limitations
The data used in this article were obtained as part of a large scoping review on 20 years of DCS use (''the anniversary paper''). 10 As it was a scoping review, we did not assess study quality. In addition, the included studies were too heterogeneous to perform meta-analyses. Therefore, when calculating mean and median scores, we distinguished only between measurement timing, ''group'' (i.e., whether people participated in a comparative study), and whether or not they received an intervention (control v. intervention group) or were part of an observational study without interventions (population). We did not control for other covariates or add weight for the number of participants per study. Moreover, we cannot rule out the possibility of regression to the mean and random effects. In addition, because of the heterogeneity of studies, we categorized the data into relatively broad categories and focused on the most frequently reported categories only. Future meta-analyses focusing on specific contexts or decisions should distinguish study groups, confounders, DESIs, and timing of the interventions (before-after measurement), to weigh the number of observations and to appraise the scientific quality of the included studies.
In addition, future studies should incorporate different versions of the DCS to see the effect of using different scales. Future research can make use of this article, our parallel descriptive paper, 10 and our established database to support meta-analyses on specific contexts, decisions, and cutoff scores for clinically significant decisional conflict.
In addition, we intend to develop DCS norm tables to be published in the DCS manual, which can function as a decisional conflict reference for different subgroups, facilitating comparison across populations.
Conclusions
The traditional DCS has been used in a range of decisional contexts and populations worldwide. Baseline DCS scores were generally above thresholds for clinically significant decisional conflict but decreased immediately after decision making, even in the absence of interventions. However, in the presence of DESIs, DCS scores tended to decrease more, and this effect remained 6 months after decision making. Mean DCS scores in this article should inform our understanding of decisional needs and fluctuations in DCS for different populations and contexts. Findings can also support future research in interpretation of DCS scores and in determining target populations or decision contexts for DESIs.
